► Subscribe to the Financial Times on YouTube: [ Ссылка ]

The European Medicines Agency has launched a new fast-track approval process for breakthrough drugs, mirroring similar schemes in the US. But can regulators strike the right balance between speed and safety?

For more video content from the Financial Times, visit [ Ссылка ]

Twitter [ Ссылка ]
Facebook [ Ссылка ]

свернуть